Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1867 1
1869 2
1870 2
1873 1
1874 1
1879 1
1885 1
1891 1
1898 3
1907 1
1914 1
1918 1
1921 1
1923 1
1929 2
1931 2
1932 2
1933 2
1934 1
1936 1
1937 2
1938 3
1939 2
1940 3
1941 1
1942 2
1943 1
1944 1
1946 3
1947 1
1948 1
1949 3
1950 1
1951 3
1952 4
1953 2
1954 2
1955 7
1956 6
1957 8
1958 8
1959 9
1960 5
1961 8
1962 12
1963 9
1964 13
1965 11
1966 7
1967 11
1968 17
1969 17
1970 17
1971 23
1972 28
1973 18
1974 20
1975 28
1976 21
1977 45
1978 38
1979 58
1980 45
1981 52
1982 56
1983 58
1984 48
1985 45
1986 58
1987 78
1988 76
1989 79
1990 72
1991 72
1992 83
1993 54
1994 65
1995 63
1996 51
1997 47
1998 47
1999 64
2000 68
2001 89
2002 93
2003 80
2004 74
2005 81
2006 70
2007 95
2008 76
2009 85
2010 87
2011 94
2012 88
2013 87
2014 96
2015 80
2016 92
2017 95
2018 99
2019 86
2020 113
2021 138
2022 129
2023 102
2024 92
2025 69

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,844 results

Results by year

Filters applied: . Clear all
Page 1
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Steinman L, Fox E, Hartung HP, Alvarez E, Qian P, Wray S, Robertson D, Huang D, Selmaj K, Wynn D, Cutter G, Mok K, Hsu Y, Xu Y, Weiss MS, Bosco JA, Power SA, Lee L, Miskin HP, Cree BAC; ULTIMATE I and ULTIMATE II Investigators. Steinman L, et al. Among authors: robertson d. N Engl J Med. 2022 Aug 25;387(8):704-714. doi: 10.1056/NEJMoa2201904. N Engl J Med. 2022. PMID: 36001711 Clinical Trial.
The origins of SARS-CoV-2: A critical review.
Holmes EC, Goldstein SA, Rasmussen AL, Robertson DL, Crits-Christoph A, Wertheim JO, Anthony SJ, Barclay WS, Boni MF, Doherty PC, Farrar J, Geoghegan JL, Jiang X, Leibowitz JL, Neil SJD, Skern T, Weiss SR, Worobey M, Andersen KG, Garry RF, Rambaut A. Holmes EC, et al. Among authors: robertson dl. Cell. 2021 Sep 16;184(19):4848-4856. doi: 10.1016/j.cell.2021.08.017. Epub 2021 Aug 19. Cell. 2021. PMID: 34480864 Free PMC article. Review.
Retraction.
Kinoshita N, Paul M, Kashiv Y, Collon P, Deibel CM, DiGiovine B, Greene JP, Jiang CL, Marley ST, Pardo RC, Rehm KE, Robertson D, Scott R, Schmitt C, Tang XD, Vondrasek R, Yokoyama A. Kinoshita N, et al. Among authors: robertson d. Science. 2023 Mar 31;379(6639):1307. doi: 10.1126/science.adh7739. Epub 2023 Mar 30. Science. 2023. PMID: 36996231 No abstract available.
Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer.
Shaukat A, Kaltenbach T, Dominitz JA, Robertson DJ, Anderson JC, Cruise M, Burke CA, Gupta S, Lieberman D, Syngal S, Rex DK. Shaukat A, et al. Among authors: robertson dj. Am J Gastroenterol. 2020 Nov;115(11):1751-1767. doi: 10.14309/ajg.0000000000001013. Am J Gastroenterol. 2020. PMID: 33156093 No abstract available.
Reply.
Shaukat A, Robertson D, Rex D. Shaukat A, et al. Among authors: robertson d. Gastroenterology. 2021 May;160(6):2220-2222. doi: 10.1053/j.gastro.2021.01.222. Epub 2021 Jan 30. Gastroenterology. 2021. PMID: 33529674 No abstract available.
Response.
Shaukat A, Robertson DJ, Burke CA, Cruise M, Lieberman DA, Anderson JC, Dominitz J, Gupta S, Rex DK. Shaukat A, et al. Among authors: robertson dj. Gastrointest Endosc. 2021 May;93(5):1198-1201. doi: 10.1016/j.gie.2021.01.044. Gastrointest Endosc. 2021. PMID: 33875148 No abstract available.
Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I study.
Newsome SD, Goldstick L, Robertson DS, Bowen JD, Naismith RT, Townsend B, Figueiredo C, Kletzl H, Giraudon M, Bortolami O, Zecevic D, Giacobino C, Clinch S, Shen YA, Deol-Bhullar G, Bermel RA. Newsome SD, et al. Among authors: robertson ds. Ann Clin Transl Neurol. 2024 Dec;11(12):3215-3226. doi: 10.1002/acn3.52229. Epub 2024 Oct 26. Ann Clin Transl Neurol. 2024. PMID: 39460719 Free PMC article. Clinical Trial.
3,844 results